Skip to main content

Table 1 Assessment measures and time points

From: Oral granulated Chinese herbal medicine (YXBCM01) plus topical calcipotriol for psoriasis vulgaris: study protocol for a double-blind, randomized placebo controlled trial

 

PASI

Body surface area

Dermatology Life Quality Index

Skindex 29

Body mass index

Chinese medicine syndrome diagnosis

Medication and health utilization

Blood tests

Check adherence

Adverse events of Chinese herbal medicine and calcipotriol

Pre-assessment (Visit 1, Week -2)

×

×

×

×

×

  

×

  

Baseline assessment (Visit 2, Week 1)

×

×

×

×

×

×

    

Daily or weekly self-assessment during 8 weeks treatment (Weeks 1 to 12)

      

×

  

×

Compliance assessment phone call (Weeks 2 and 4)

        

×

×

Mid-treatment assessment (Visit 3, Week 6)

×

×

×

×

×

  

× (liver and kidney function only)

×

×

Compliance assessment phone call (Week 8 and 10)

        

×

×

End of treatment assessment (Visit 4, Week 12)

×

×

×

×

×

×

×

×

×

×

Daily or weekly self-assessment during 12 weeks follow-up (weeks 13 to 24)

      

×

  

×

End of follow-up assessment (Visit 5 or Week 24)

×

×

×

×

×

×

×

×

×

×

  1. PASI Psoriasis Area and Severity Index.